Skip to main content
. 2018 Jun 25;99(3):649–664. doi: 10.4269/ajtmh.18-0115

Table 4.

Twenty eight-day efficacy of AA, AL, or DHP according to study sites

PCR-uncorrected on day 28 PCR-corrected on day 28
Study sites ACRP_u Failure_u Total % Cure rate ACPR_c Recrudescence Total % Recrudescence
All treatments
 Numan (Adamawa) 154 12 166 92.8 144 6 150 4
 Neni (Anambra) 35 9 44 79.5 16 0 16 0
 Otuasegha (Bayelsa) 76 7 83 91.6 72 1 73 1.4
 Ogwa (Imo) 142 9 151 94 93 0 93 0
 Kura (Kano) 155 5 160 96.9 142 0 142 0
 Ilorin (Kwara) 66 5 71 93 34 0 34 0
 Ibadan (Oyo) 46 1 47 97.9 44 0 44 0
 Bodinga (Sokoto) 116 11 127 91.3 43 1 44 2.3
 All sites 790 59 849 93.1 588 8 596 1.5
AA
 Numan (Adamawa) 52 3 55 94.5 46 2 48 4.2
 Neni (Anambra) 8 5 13 61.5 4 0 5 0
 Otuasegha (Bayelsa) 27 3 30 90 24 1 25 4
 Ogwa (Imo) 49 5 54 90.7 35 0 35 0
 Kura (Kano) 52 0 52 100 45 0 45 0
 Ilorin (Kwara) 16 2 18 88.9 10 0 10 0
 Ibadan (Oyo) 12 1 13 92.3 11 0 11 0
 Bodinga (Sokoto) 35 6 41 85.4 14 1 15 6.7
 All sites 251 25 276 90.9 189 4 193 2.1
AL
 Numan (Adamawa) 47 9 56 83.9 47 4 51 7.8
 Neni (Anambra) 10 2 12 83.3 5 0 5 0
 Otuasegha (Bayelsa) 21 2 23 91.3 22 0 22 0
 Ogwa (Imo) 46 2 48 95.8 23 0 23 0
 Kura (Kano) 50 5 55 90.9 50 0 50 0
 Ilorin (Kwara) 20 3 23 87 9 0 9 0
 Ibadan (Oyo) 15 0 15 100 14 0 14 0
 Bodinga (Sokoto) 44 2 46 95.7 17 0 17 0
 All sites 253 25 278 91 187 4 191 2.1
DHP
 Numan (Adamawa) 55 0 55 100 51 0 51 0
 Neni (Anambra) 17 2 19 89.5 7 0 7 0
 Otuasegha (Bayelsa) 28 2 30 93.3 26 0 26 0
 Ogwa (Imo) 47 2 49 95.9 35 0 35 0
 Kura (Kano) 53 0 53 100 47 0 47 0
 Ilorin (Kwara) 30 0 30 100 15 0 15 0
 Ibadan (Oyo) 19 0 19 100 19 0 19 0
 Bodinga (Sokoto) 37 3 40 92.5 12 0 12 0
 All sites 286 9 295 96.9 212 0 212 0

AA = artesunate–amodiaquine; ACPR_c = adequate clinical and parasitological response corrected; ACPR_u = adequate clinical and parasitological response uncorrected; AL = artemether–lumefantrine; DHP = dihydroartemisinin–piperaquine; Failure_u = treatment failure uncorrected; PCR = polymerase chain reaction.